Results 221 to 230 of about 38,429 (312)
Elevated Monocytes in Patients with Critical Limb Ischemia Diminish After Bypass Surgery [PDF]
Dania Magri +7 more
openalex +1 more source
A stable kidney normothermic machine perfusion model with sevoflurane delivery via a vaporizer was established, enabling mechanistic and therapeutic studies of ischemia–reperfusion injury. ABSTRACT Normothermic machine perfusion (NMP) of donor kidneys provides an opportunity not only for organ preservation but also for therapeutic intervention to ...
Philip N. Günkel +10 more
wiley +1 more source
Technical Pitfalls and Tips of Management for Critical Limb Ischemia by Distal Bypass Using the Autogenous Veins. [PDF]
Kokubo T +3 more
europepmc +1 more source
Antimicrobial prescribing guidelines for horses in Australia
The growing problem of antimicrobial resistance also affects equine veterinarians with increasing frequency. Antimicrobial stewardship and responsible prescribing are essential for a future in which effective antimicrobials are available, as it is unlikely that new antimicrobials will become available for use in horses.
L Hardefeldt +18 more
wiley +1 more source
Extracorporeal shockwave therapy rescued mouse critical limb ischemia via upregulating GPR120 against inflammation and promoting angiogenesis for restoring the blood flow in ischemic zone-experimental study. [PDF]
Sung PH +8 more
europepmc +1 more source
Bone marrow stem cell injection for the treatment of critical limb ischemia
Shunya Shindo
openalex +1 more source
2020 JAPAN Critical Limb Ischemia Database (JCLIMB) Annual Report. [PDF]
Japanese Society for Vascular Surgery JCLIMB Committee +1 more
europepmc +1 more source
Time to Redefine Critical Limb Ischemia
Matthew C. Bunte, Mehdi H. Shishehbor
openaire +3 more sources
Background and Purpose Inflammation plays a crucial role in the development and progression of numerous acute and chronic diseases such as myocardial infarction (MI) and heart failure. Targeting ADAM proteases, particularly ADAM10, holds promise for fine‐tuning inflammatory responses.
Erik Klapproth +16 more
wiley +1 more source

